MELANOMA STAGE III OR IV
Clinical trials for MELANOMA STAGE III OR IV explained in plain language.
Never miss a new study
Get alerted when new MELANOMA STAGE III OR IV trials appear
Sign up with your email to follow new studies for MELANOMA STAGE III OR IV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to boost immune attack on tough melanoma
Disease control OngoingThis study tests a new drug, BI-1607, added to two existing immunotherapy drugs (ipilimumab and pembrolizumab) for people with advanced melanoma that has spread or can't be removed. The goal is to see if the combination is safe and helps the immune system fight cancer better. Abo…
Matched conditions: MELANOMA STAGE III OR IV
Phase: PHASE1, PHASE2 • Sponsor: BioInvent International AB • Aim: Disease control
Last updated May 17, 2026 06:30 UTC
-
Melanoma survivors: could immunotherapy harm your heart years later?
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at whether melanoma survivors who received immunotherapy (immune checkpoint inhibitors) may have long-term heart problems, such as increased risk of heart attack. Researchers will invite 60 people who finished treatment 2 to 10+ years ago to undergo heart tests. …
Matched conditions: MELANOMA STAGE III OR IV
Sponsor: Royal Marsden NHS Foundation Trust • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC